165 related articles for article (PubMed ID: 9704014)
1. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
[TBL] [Abstract][Full Text] [Related]
2. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
[TBL] [Abstract][Full Text] [Related]
5. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
6. Mutated Atf4 suppresses c-Ha-ras oncogene transcript levels and cellular transformation in NIH3T3 fibroblasts.
Mielnicki LM; Hughes RG; Chevray PM; Pruitt SC
Biochem Biophys Res Commun; 1996 Nov; 228(2):586-95. PubMed ID: 8920955
[TBL] [Abstract][Full Text] [Related]
7. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
8. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
[TBL] [Abstract][Full Text] [Related]
9. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
10. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
11. Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.
Isonishi S; Hom DK; Thiebaut FB; Mann SC; Andrews PA; Basu A; Lazo JS; Eastman A; Howell SB
Cancer Res; 1991 Nov; 51(21):5903-9. PubMed ID: 1657373
[TBL] [Abstract][Full Text] [Related]
12. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
Schwartz SA; Shuler CF; Freebeck P
Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
[TBL] [Abstract][Full Text] [Related]
13. Multiple Harvey-ras genes in the bovine genome.
McCaffery RE; Coggins LW; Doherty I; Kennedy I; O'Prey M; McColl L; Campo MS
Oncogene; 1989 Dec; 4(12):1441-8. PubMed ID: 2687766
[TBL] [Abstract][Full Text] [Related]
14. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
15. [Transfer of active oncogenes and promoters into the mouse cell genome].
Tatosian AG; Topol' LZ; Ambartsumian NS
Mol Biol (Mosk); 1986; 20(5):1226-35. PubMed ID: 3022122
[TBL] [Abstract][Full Text] [Related]
16. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
Miyamoto S; Guzman RC; Shiurba RA; Firestone GL; Nandi S
Cancer Res; 1990 Sep; 50(18):6010-4. PubMed ID: 2203525
[TBL] [Abstract][Full Text] [Related]
17. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
[TBL] [Abstract][Full Text] [Related]
18. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
[TBL] [Abstract][Full Text] [Related]
19. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
20. Replication-competent and -defective retrovirus vectors for oncogenic studies.
Samarut J; Flamant F; Heard JM
Methods Enzymol; 1995; 254():206-28. PubMed ID: 8531688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
